These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3321940)

  • 1. The paradox of immunization against Haemophilus influenzae-related endobronchitis: protection restricted to ingestion of 'non-adjuvenated' vaccine.
    Clancy R; Cripps A; Pang G; Yeung S; Murree-Allen K
    Adv Exp Med Biol; 1987; 216B():1759-64. PubMed ID: 3321940
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection induced against acute bronchitis--the use of human and rat models to determine mechanisms of action of oral immunization with Haemophilus influenzae.
    Clancy RL; Wallace FJ; Cripps AW; Pang GT
    Curr Top Microbiol Immunol; 1989; 146():181-5. PubMed ID: 2786462
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease.
    Clancy R; Cripps A; Murree-Allen K; Yeung S; Engel M
    Lancet; 1985 Dec 21-28; 2(8469-70):1395-7. PubMed ID: 2867396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis.
    Tandon MK; Gebski V
    Aust N Z J Med; 1991 Aug; 21(4):427-32. PubMed ID: 1953532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae.
    Clancy RL; Cripps AW; Gebski V
    Med J Aust; 1990 Apr; 152(8):413-6. PubMed ID: 2184330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific protection against acute bronchitis associated with nontypeable Haemophilus influenzae.
    Clancy RL; Cripps AW
    J Infect Dis; 1992 Jun; 165 Suppl 1():S194-5. PubMed ID: 1588162
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea.
    Lehmann D; Coakley KJ; Coakley CA; Spooner V; Montgomery JM; Michael A; Riley ID; Smith T; Clancy RL; Cripps AW
    Am Rev Respir Dis; 1991 Aug; 144(2):324-30. PubMed ID: 1859055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine.
    Ward J
    Pediatrics; 1990 Apr; 85(4 Pt 2):667. PubMed ID: 2179858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vaccination against Haemophilus influenzae].
    Huber EG
    Padiatr Padol; 1991; 26(4):203-4. PubMed ID: 1749631
    [No Abstract]   [Full Text] [Related]  

  • 10. [When should vaccination against Haemophilus influenzae type b take place?].
    Stickl HA
    Med Monatsschr Pharm; 1991 Jan; 14(1):24. PubMed ID: 2017108
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilus influenzae type b prevention.
    N Y State J Med; 1989 Jul; 89(7):430-1. PubMed ID: 2788257
    [No Abstract]   [Full Text] [Related]  

  • 12. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update.
    Pediatrics; 1991 Jul; 88(1):169-72. PubMed ID: 2057256
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal responsiveness as a determinant of protection mechanisms induced by oral immunization.
    Clancy R; Pang G; Cripps A
    Adv Exp Med Biol; 1995; 371B():1417-22. PubMed ID: 7502830
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of antigen-reactive and IL-2 receptor bearing cells following oral immunization in humans.
    Pang GT; Yeung SY; Clancy RL; Chipchase H; Cripps AC
    Adv Exp Med Biol; 1987; 216B():1731-9. PubMed ID: 3122536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H. influenzae vaccine for infants.
    Med Lett Drugs Ther; 1991 Jan; 33(836):5-7. PubMed ID: 1986208
    [No Abstract]   [Full Text] [Related]  

  • 16. Further immunologic evaluation of children who develop haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Sheetz KE; Nahm MH; Madassery JV; Shackelford PG
    Monogr Allergy; 1988; 23():256-68. PubMed ID: 3260336
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunization for invasive Haemophilus influenzae type b infections: present and future].
    Dagan R; Einhorn M
    Harefuah; 1990 Apr; 118(8):470-5. PubMed ID: 2192956
    [No Abstract]   [Full Text] [Related]  

  • 18. Expert panel convened by FDA recommends Haemophilus influenzae type B vaccine should continue in use for children older than 2 years.
    Marwick C
    JAMA; 1987 Jun; 257(23):3182-3. PubMed ID: 3495673
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of oral immunization against non-typable Haemophilus influenzae in man.
    Yeung S; Pang G; Cripps AW; Clancy RL; Wlodarczyk JH
    Int J Immunopharmacol; 1987; 9(3):283-8. PubMed ID: 3301699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.